FNDC4 acts as an extracellular factor to promote the invasiveness of hepatocellular carcinoma partly via the PI3K/Akt signalling pathway
Authors:
Open Access
- 21 August 2021
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 10 (20) , 7242-7252
Abstract
FNDC4 is highly homologous to the exercise-associated myokine FNDC5/irisin, which is highly expressed and promotes the invasion and metastasis of HCC cells. However, the function of FNDC4 remains unknown. Here, we report that FNDC4, an extracellular factor, plays important roles in the invasion and metastasis of HCC. We found that high FNDC4 expression is associated with poor survival in HCC patients and FNDC4 promotes the migration and invasion of HCC cells. Mechanistically, we found that FNDC4 is related to the PI3K/Akt signalling pathway to a certain extent. Specifically, the extracellular domain of FNDC4 acts as an extracellular factor to promote Akt phosphorylation levels in this pathway. These findings reveal that FNDC4 promotes the invasion and metastasis of HCC partly via the PI3K/Akt signalling pathway.Keywords
Funding Information
- National Natural Science Foundation of China (81670597, 81972303)
This publication has 16 references indexed in Scilit:
- FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytesMetabolism, 2020
- Fibronectin type III domain containing four promotes differentiation of C2C12 through the Wnt/β‐catenin signaling pathwayThe FASEB Journal, 2020
- Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 2017
- Emerging Biological Principles of MetastasisCell, 2017
- Increased FNDC5/Irisin expression in human hepatocellular carcinomaPeptides, 2017
- FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in miceNature Communications, 2016
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial DesignClinical Cancer Research, 2014
- Frcp1 and Frcp2, two novel fibronectin type III repeat containing genesGene, 2002
- Adhesion in cell migrationCurrent Opinion in Cell Biology, 1995
- Liver CancerCA: A Cancer Journal for Clinicians, 1989